Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research Progress of Chinese Medicine in the Treatment of Myelosuppression after Chemotherapy for Malignant Tumours

Download as PDF

DOI: 10.23977/tranc.2024.050103 | Downloads: 9 | Views: 415

Author(s)

Bai Chongliang 1, Liu Li 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

Corresponding Author

Liu Li

ABSTRACT

Malignant tumours are common diseases in oncology, with irregular lifestyles, smokers and drinkers being the most prevalent groups. The common clinical symptoms are local mass, pain, ulceration, bleeding and obstruction. Chemotherapy is a commonly used treatment for malignant tumours, but myelosuppression easily occurs after chemotherapy is still the biggest problem in current cancer treatment, and if there is no "adjuvant" measure, it will lead to the deterioration of the disease, so that chemotherapy fails. Therefore, this paper focuses on the research progress of Chinese medicine in the treatment of post-chemotherapy myelosuppression of malignant tumours, with a view to providing some referential suggestions for clinical treatment.

KEYWORDS

Chinese medicine; malignant tumour; post-chemotherapy; myelosuppression

CITE THIS PAPER

Bai Chongliang, Liu Li, Research Progress of Chinese Medicine in the Treatment of Myelosuppression after Chemotherapy for Malignant Tumours. Transactions on Cancer (2024) Vol. 5: 18-27. DOI: http://dx.doi.org/10.23977/tranc.2024.050103.

REFERENCES

[1] Fang Xupeng, Fang Dan, Wang Wei, et al. Review of TCM Treatment of Leukopenia after Chemotherapy for Malignant Tumor [J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, 2022, 24(7):2539-2544. 
[2] Jia Huosheng, Zhao Chunni. Research Progress of Bone Marrow Suppression after Chemotherapy of Malignant Tumor Treated with Traditional Chinese Medicine[J]. Journal of Sichuan of Traditional Chinese Medicine, 2018, 36(2):219-222. 
[3] Ren Huashan, Yan Ping, Hou Yuduo. Research Progress on Moxibustion Therapy for Bone Marrow Suppression and Immune Regulation after Chemotherapy for Malignant Tumors[J]. World Chinese Medicine, 2022, 17(24):3549-3558. 
[4] Chen Zhaohui, Lin Xianlei, Lin Shengyou. Research progress on intervention of traditional Chinese medicine in the signaling pathways of chemotherapy-induced hematopoietic stem cell senescence[J]. Shanghai Journal of Traditional Chinese Medicine, 2017, 51(2): 89-92. 
[5] Fan Kui, Dai Liangmin, Wu Zhenfeng, et al. Advances in chemotherapy-induced myelosuppression[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2017, 32(1): 210-214. 
[6] Wang Xiaoqun, Yang Peiying, Sun Binyu, et al. Professor Jia Yingjie's experience in treating myelosuppression after chemotherapy for malignant tumours[J]. Lishizhen Medicine and Materia Medica Research, 2013:747-748. 
[7] Hou Tianjiang, Shang Jing, Zhu Jie, et al. TCM Pathogenesis and Clinical Treatment Analysis of Chemotherapy-induced Bone Marrow Suppression[J]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica, 2016, 37(9):31-33. 
[8] Li Kexin, Cao Yong. Exploring the treatment of myelosuppression after chemotherapy from the method of strengthening the spleen and tonifying the kidney to eliminate blood stasis [J]. Journal of Basic Chinese Medicine, 2012, 18(4):410-411.
[9] Qin Lin, Xu Chengyong, Wang Yuguo, et al. Treating Bone Marrow Suppression after Chemotherapy by Boosting Qi-Nourishing Blood and Fortifying the Spleen-Supplementing the Kidney[J]. Journal of Traditional Chinese Medicine, 2017, 58(12):1017-1020. 
[10] Yang Yan. Role and care of millimetre wave therapy on myelosuppression after chemotherapy for malignant tumours [J]. Electronic Journal of Practical Clinical Nursing, 2018, 3(4):143-149. 
[11] Liu Huanbin. Progress of research on bone marrow suppression after chemotherapy of malignant tumours treated with Chinese medicine[J]. Inner Mongolia Journal of Traditional Chinese Medicine, 2020, 10(10):163-165. 
[12] An Na, Zhang Guying, Zhao Yile, et al. Clinical Medication Rule of Traditional Chinese Medicine in the Treatment of Bone Marrow Suppression Stage After Chemotherapy in Acute Leukemia Based on Data Mining[J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2021, 21(4):1250-1253+1257. 
[13] He Huaiyang, Xie Changsheng. Clinical Progress of Traditional Chinese Medicine in Treatment of Myelosuppression Induced by Chemotherapy for Malignancy[J]. Journal of Traditional Chinese Medical Literature, 2017, 35(2):67-70. 
[14] Liu Qingyuan, He Ruoping. The Clinical Experience of Professor He Ruoping in the Treatment of Bone Marrow Suppression after Chemotherapy in Patients with Malignant Tumor[J]. Journal of Zhejiang Chinese Medical University, 2016, 40(10):744-746. 
[15] Xu Zuhong, Qin Jingru, Wang Zhongqi. Progress of clinical and experimental research on Chinese medicine against myelosuppression after chemotherapy for malignant tumours[J]. Jiangxi Journal of Traditional Chinese Medicine, 2016, 47(4):74-76. 
[16] Wang Shuting, Fan Jingqi, Zhuang Lixing, et al. Discussion on Thoughts of ZHUANG Li-xin for Treatment of Bone Post-chemotherapy Marrow Suppression of Malignant Tumor by Using Direct Moxibustion on Sihua Point[J]. Journal of Oncology in Chinese Medicine, 2022, 4(2):51-54. 
[17] Huang Zijing, Lin Lizhu. Research progress of adverse reactions related to differentiation of lung cancer by traditional Chinese medicine[J]. World Clinical Drugs, 2021, 42(5):340-344. 
[18] Fu Zifeng. Clinical observation of Jiawei Yuji Wan in reducing bone marrow suppression after chemotherapy for malignant tumour (spleen and kidney yang deficiency) [D]. Changsha: Hunan University of Traditional Chinese Medicine, 2021. 
[19] Zhao Minmin, Lu Su. Progress in the prevention and treatment of myelosuppression in Chinese medicine after chemotherapy for malignant tumours[J]. Global Traditional Chinese Medicine, 2015, 8(S2):274. 
[20] Lu Zhaohui, Han Huifang. Analysis of the pathogenesis and clinical treatment of myelosuppression after chemotherapy for malignant tumours[J]. Hebei Medical Journal, 2015, 37(16):2460-2462. 
[21] Wu Yong. Evaluation of the efficacy of spacer moxibustion in the treatment of myelosuppression after tumour chemotherapy [D]. Guangzhou: Guangzhou University of Traditional Chinese Medicine, 2014:1-50.
[22] Wang Yu, Wei Zhanning, ZhangWeiping, et al. Adjuvant Function of Guilu Erxian Glue Cataplasm in Treating Carcinoma of the Large Intestine Patients with Myelosuppression after Chemotherapy:a Clinical Observation[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2014, 34(8):947-951.
[23] Wang Jiannan, Zhang Weixing, Gu Qunhao, et al. Protection of Herb-partitioned Moxibustion on Bone Mmarrow Suppression of Gastric Cancer Patients in Chemotherapy Period[J]. Chinese Archives of Traditional Chinese Medicine, 2014, 32(12):2922-2925. 
[24] Zhang Ying, Luo Yinxing, Cai Xiaoping, et al. Clinical observation on the treatment of Leukocytopenia after chemotherapy in 45 patients with malignant tumor receiving herbs-partitioned moxibustion[J]. Pharmacy and Clinics of Chinese Materia Medica, 2013, 4(5):42-43+53. 
[25] Yang Jia'en. Clinical observation of warm acupuncture in the treatment of leukopenia after chemotherapy[D]. Hubei: Hubei University of Traditional Chinese Medicine, 2013:1-47. 
[26] Ji Yajie, Li Siyu, Zhang Xinyue, et al. The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study[J]. Evidence-Based Complementary and Alternative Medicine, 2021, 2021:1347342-1347342. 
[27] Lu Mei, Du Xueyuan, Teng Yingchun, et al. Effects of Acupuncture and Moxibustion on Differentially Expressed Genes No.1, No.2 of Notch Signaling Pathway-related in Bone Marrow Hematopoietic Cells in Cyclophosphamide-induced Mice[J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(9):2055-2058. 
[28] Du Pengpeng. Effects of moxibustion and foot-sanli on leukocyte levels and toxic side effects after chemotherapy in patients with cervical cancer[J]. Famous Doctor, 2019, 10(9):10+13. 
[29] Xiao Xianhui, Jia Runmiao, Li Hongke, et al. Clinical Study on Efficacy of Moxibustion at Zusanli (ST36) to Treat Myelosuppression in Patients Receiving Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer[J]. Clinical Journal of Traditional Chinese Medicine, 2019, 31(2):339-342. 
[30] Zhang Qufei, Li Linxia, Fan Duying. Efficacy of moxibustion on marrow restraint in patiens with lung cancer after chemotherapy [J]. Clinical Journal of Chinese Medicine, 2017, 9(7):24-25+27. 
[31] Lin Wanbing, Zhou Jieying, Jiang Bei, et al. Therapeutic Observation of Ginger-partitioned Moxibustion in Treating Myelosuppression Induced by Chemotherapy for Multiple Myeloma[J]. Shanghai Journal of Acupuncture and Moxibustion, 2017, 36(7):816-820. 
[32] Yan Yuetai, Shen Dan, Ruan Yingdan, et al. Effects of moxibustion at Guanyuan and Qihai points on quality of life in patients with advanced liver cancer[J]. Chinese Journal of General Practice, 2017, 15(7):1227-1229. 
[33] Zhang Chunying, Wu Zhongfang. Observation of the effect of interspersed ginger moxibustion combined with Rebaud's on myelosuppression after chemotherapy in patients with malignant tumours and nursing care [J]. Guide of China Medicine, 2014, 12(4):213-214. 
[34] Zhang Lanhui, Huang Ruqin, Zhang Hui, et al. Clinical study on 31 cases of moxibustion combined with Angelica sinensis blood tonic soup to prevent myelosuppression after tumour chemotherapy[J]. Jiangsu Journal of Traditional Chinese Medicine, 2019, 51(12):67-69. 
[35] Xiao Caizhi, Wang Wei, Xia Dongqin. Clinical Study of Moxibustion Combined with Acupoint Application of Chinese Medicine on Prevention and Treatment of Post-chemotherapy Bone Marrow Depression in Patients with Malignant Tumo [J]. Journal of Oncology in Chinese Medicine, 2019, 1(3):30-33.

Downloads: 533
Visits: 33287

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.